Match Document Document Title Score
US20140024553 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-smail cell lung cancer or reactive airway disease. Measurements of these biomarkers...
1000
WO/2015/066564A1 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. Measurements of these biomarkers...
954
WO/2012/149550A1 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-smail cell lung cancer or reactive airway disease. Measurements of these biomarkers...
951
EP2702411A4 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF   742
8541183 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof  
The invention provides biomarkers and combinations of biomarkers that are useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also...
730
EP2702411A1 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF   725
US20100009386 METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers that are useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also...
704
US20140378425 BIOMARKERS FOR DIAGNOSIS OF LUNG DISEASES AND METHODS OF USE THEREOF  
The present disclosure provides methods for diagnosis of interstitial lung diseases (ILDs). The present disclosure provides methods for differential diagnosis of idiopathic pulmonary fibrosis from...
703
US20140309123 METHODS FOR LUNG CANCER CLASSIFICATION  
The present invention provides specific nucleic acid sequences for use in the identification, classification and diagnosis of various sub-types of lung cancers. The present invention permits one...
697
US20120302455 METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides...
676
WO/2014/144564A2 BIOMARKERS FOR DIAGNOSIS OF LUNG DISEASES AND METHODS OF USE THEREOF  
The present disclosure provides methods for diagnosis of interstitial lung diseases (ILDs). The present disclosure provides methods for differential diagnosis of idiopathic pulmonary fibrosis from...
658
8735074 MiRNA biomarkers of lung disease  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
655
EP2775300A2 miRNA Biomarkers of Lung Disease  
miRNAs may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis,...
636
WO/2015/018964A1 METHOD FOR CLASSIFICATION, DIAGNOSIS AND MONITORING OF INDIVIDUALS AT RISK OF SUFFERING FROM LUNG CANCER BY MEANS OF SWEAT ANALYSIS  
The invention relates to a method for obtaining useful data for classification, diagnosis and monitoring of lung cancer. The invention also relates to a kit for classification, diagnosis and...
631
US20110053158 MIRNA BIOMARKERS OF LUNG DISEASE  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
623
9297805 Compositions, methods and kits for diagnosis of lung cancer  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
616
EP2857522A2 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides...
616
US20140274791 miRNA BIOMARKERS OF LUNG DISEASE  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
613
9588127 Compositions, methods and kits for diagnosis of lung cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
612
9201044 Compositions, methods and kits for diagnosis of lung cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
611
9304137 Compositions, methods and kits for diagnosis of lung cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
602
8637232 Biomarkers for lung disease monitoring  
The present invention pertains to the monitoring and treatment of lung transplant recipients. In particular, the invention pertains to the use of biomarkers to predict or detect post-lung...
601
US20150031065 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
594
US20160161493 Compositions, Methods and Kits for Diagnosis of Lung Cancer  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
590
7807392 Lung disease targets and uses thereof  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
589
US20150087728 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
588
US20160047820 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
588
7521195 Lung disease targets and uses thereof  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
585
WO/2011/025919A1 MIRNA BIOMARKERS OF LUNG DISEASE  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
584
US20130217057 Compositions, Methods and Kits for Diagnosis of Lung Cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
584
WO/2010/105235A2 METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF INCLUDING GENDER-BASED DISEASE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides...
578
US20130230877 Compositions, Methods and Kits for Diagnosis of Lung Cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
578
WO/2015/187612A1 METHOD AND SYSTEMS FOR LUNG CANCER DIAGNOSIS  
The present invention relates to methods and systems for high risk screening, diagnosis, prognosis, and surveillance of lung cancer. Accordingly, in one aspect, the invention provides a method for...
574
WO/2014/100717A2 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
572
WO/2003/029273A2 CLASSIFICATION OF LUNG CARCINOMAS USING GENE EXPRESSION ANALYSIS  
The invention provides a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Oligonucleotide micro arrays were used to analyze mRNA...
571
WO/2013/096845A2 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
570
WO/2015/042454A1 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
569
US20040009489 Classification of lung carcinomas using gene expression analysis  
The invention provides a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Oligonucleotide microarrays were used to analyze mRNA...
568
US20110212085 LUNG CANCER DISEASE TARGETS AND USES THEREOF  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
567
WO/2015/013654A1 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
566
US20090232822 LUNG DISEASE TARGETS AND USES THEREOF  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
566
US20110219464 LUNG DISEASE TARGETS AND USES THEREOF  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
563
JP2016006426A METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF INCLUDING IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF DISEASES BASED ON GENDER  
PROBLEM TO BE SOLVED: To provide a biomarker useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease, a combination of the biomarkers, a method of...
553
US20160169900 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
552
US20150141278 MULTIPLEXED ASSAY METHOD FOR LUNG CANCER CLASSIFICATION  
A method for providing a composite image of a single biological sample from a patient suspected of having lung cancer, comprising the steps of generating a first image of the biological sample,...
552
US20110136140 DIAGNOSIS OF SYSTEMIC DISEASES  
It has been found that the pattern of recognized topo I epitopes is different between dcSSc, IcSSc and SLE patients. Fragment F4 (amino acid (AA) 450-600) was recognized by all patients tested....
551
WO/2010/010514A1 DIAGNOSIS OF SYSTEMIC DISEASES  
It has been found that the pattern of recognized topo I epitopes is different between dcSSc, IcSSc and SLE patients. Fragment F4 (amino acid (AA) 450-600) was recognized by all patients tested....
544
WO/2006/039819A1 MARKERS OF LUNG INJURY  
The invention relates to novel markers of lung injury, methods for assessing the status of lung tissue using the markers, and methods for the diagnosis and therapy of lung injuries.
542
WO/2013/181127A1 MULTIPLEXED ASSAY METHOD FOR LUNG CANCER CLASSIFICATION  
A method for providing a composite image of a single biological sample from a patient suspected of having lung cancer, comprising the steps of generating a first image of the biological sample,...
541
8377637 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P  
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of lung cancer. The invention also provides methods of identifying anti-lung cancer agents.
540


Search
« search again